Description: The peptide is used to block Anti-SSX-pan Antibody (#CPA2107) reactivity. Form: Lyophilized powder Gene Symbol: SSX1; SSX2; SSX3; SSX4; SSX5; SSX6; SSX7; SSX8; SSX9 Alternative Names: SSX1; Protein SSX1; Cancer/testis antigen 5.1; CT5.1; Synovial sarcoma, X breakpoint 1; SSX2; SSX2A; SSX2B; Protein SSX2; Cancer/testis antigen 5.2; CT5.2; Synovial sarcoma, X breakpoint 2; Tumor antigen HOM-MEL-40; SSX3; Protein SSX3; Cancer/testis antigen 5.3; CT5.3; SSX4; SSX4A; SSX4B; Protein SSX4; Cancer/testis antigen 5.4; CT5.4; SSX5; Protein SSX5; SSX6; Putative protein SSX6; SSX7; Protein SSX7; SSX8; Protein SSX8; SSX9; Protein SSX9Entrez Gene (Human): 6756; 6757; 727837; 10214; 548313; 6759; 6758; 280658SwissProt (Human): Q16384; Q16385; Q99909; O60224; O60225; Q7RTT6; Q7RTT5; Q7RTT4; Q7RTT3Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.